Koers BetterLife Pharma Inc. Other OTC
Aandelen
BETRF
CA08772P2026
Biotechnologie & Medisch Onderzoek
Omzet 2023 | - | Omzet 2024 | - | Marktkapitalisatie | 8,69 mln. 8,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -9 mln. -8,38 mln. | Nettowinst (verlies) 2024 | -2 mln. -1,86 mln. | EV/omzet 2023 | - |
Nettoschuld 2023 | 71,69K 66,75K | Nettoschuld 2024 | 290K 270K | EV/omzet 2024 | - |
K/w-verhouding 2023 |
-1,36
x | K/w-verhouding 2024 |
-2,84
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 |
-
| Vrij verhandelbaar | 72,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26-12-10 |
Chief Operating Officer | 67 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,34% | 125 mld. | |
+15,06% | 108 mld. | |
-6,39% | 23,64 mld. | |
+2,39% | 22,39 mld. | |
-12,11% | 17,78 mld. | |
-41,64% | 16,43 mld. | |
-12,07% | 16,34 mld. | |
+1,05% | 13,56 mld. | |
+25,87% | 11,59 mld. |